{"version":"company-facts.v1","source":"https://secwatch.observer","generated_at":"2026-06-18T17:18:38.457806+00:00","company":{"ticker":"OMDA","cik":1611115,"company_name":"Omada Health, Inc."},"pagination":{"limit":100,"returned":7,"next_cursor":null},"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer","counterparties":{},"facts":[{"fact_type":"shareholder_vote","fact_key":"2bcb06a344e782002fa77221f8430a6d7cece401","cik":1611115,"ticker":"OMDA","company_name":"Omada Health, Inc.","filed_at":"2026-06-16T20:08:13+00:00","payload":{"item_codes_triggered":["5.07"],"meeting_date":"2026-06-16","outcome":"passed","proposal_text":"Ratification of the Appointment of Independent Registered Public Accounting Firm","proposal_type":"auditor_ratification","results":[{"broker_non_votes":"0","subject":null,"votes_abstain":"27,282","votes_against":"16,905","votes_for":"41,550,689","votes_withheld":null}]},"claim":"Omada Health, Inc. shareholders approved Ratification of the Appointment of Independent Registered Public Accounting Firm at the 2026-06-16 meeting.","evidence_excerpt":"Proposal Two – Ratification of the Appointment of Independent Registered Public Accounting Firm FOR AGAINST ABSTAIN 41,550,689 16,905 27,282","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001628280-26-043537","anchor_url":"https://secwatch.observer/filing/0001628280-26-043537#claim-2bcb06a344e782002fa77221f8430a6d7cece401","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1611115/000162828026043537/0001628280-26-043537-index.htm"},{"fact_type":"shareholder_vote","fact_key":"ba7cffeee39ce0f24221ca8b4cab58e3ebc556cf","cik":1611115,"ticker":"OMDA","company_name":"Omada Health, Inc.","filed_at":"2026-06-16T20:08:13+00:00","payload":{"item_codes_triggered":["5.07"],"meeting_date":"2026-06-16","outcome":"passed","proposal_text":"Election of Class I Directors: Sean Duffy and Trevor Fetter","proposal_type":"director_election","results":[{"broker_non_votes":"13,920,625","subject":"Sean Duffy","votes_abstain":null,"votes_against":null,"votes_for":"18,540,089","votes_withheld":"9,134,162"},{"broker_non_votes":"13,920,625","subject":"Trevor Fetter","votes_abstain":null,"votes_against":null,"votes_for":"18,538,042","votes_withheld":"9,136,209"}]},"claim":"Omada Health, Inc. shareholders approved Election of Class I Directors: Sean Duffy and Trevor Fetter at the 2026-06-16 meeting.","evidence_excerpt":"The final voting results for each of these proposals are as follows: Proposal One - Election of Class I Directors NOMINEE FOR WITHHELD BROKER NON-VOTERS Sean Duffy 18,540,089 9,134,162 13,920,625 Trevor Fetter 18,538,042 9,136,209 13,920,625","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001628280-26-043537","anchor_url":"https://secwatch.observer/filing/0001628280-26-043537#claim-ba7cffeee39ce0f24221ca8b4cab58e3ebc556cf","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1611115/000162828026043537/0001628280-26-043537-index.htm"},{"fact_type":"earnings_release","fact_key":"81f6268374f1ff239ddd18baf70b90309c71c4c1","cik":1611115,"ticker":"OMDA","company_name":"Omada Health, Inc.","filed_at":"2026-05-07T23:59:59+00:00","payload":{"eps_text":null,"guidance_signal":"none","item_codes_triggered":["2.02"],"net_income_text":"Net loss of $3 million in the first quarter","period_text":"first quarter ended March 31, 2026","report_date":"2026-05-07","result_type":"reported_results","revenue_text":"$78 million in the first quarter"},"claim":"Omada Health, Inc. reported first quarter ended March 31, 2026 results: revenue $78 million in the first quarter, net income Net loss of $3 million in the first quarter.","evidence_excerpt":"million Total Members at the end of Q1, up 51% year over year, reinforcing Omada’s role as an integrated, multi-condition cardiometabolic platform operating at scale. • Revenue: $78 million in the first quarter, up 42% year over year. • Omada joined Optum Rx’s Weight Engage portfolio to help employers expand responsible, clinically supported access to GLP‐1 and","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001628280-26-032063","anchor_url":"https://secwatch.observer/filing/0001628280-26-032063#claim-81f6268374f1ff239ddd18baf70b90309c71c4c1","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1611115/000162828026032063/0001628280-26-032063-index.htm"},{"fact_type":"earnings_release","fact_key":"c839efe7160af61da869c55b6ea39a5383f149de","cik":1611115,"ticker":"OMDA","company_name":"Omada Health, Inc.","filed_at":"2026-03-05T23:59:59+00:00","payload":{"eps_text":null,"guidance_signal":"none","item_codes_triggered":["2.02"],"net_income_text":"net loss of $13 million","period_text":"the full year ended December 31, 2025","report_date":"2026-03-05","result_type":"reported_results","revenue_text":"$260 million"},"claim":"Omada Health, Inc. reported the full year ended December 31, 2025 results: revenue $260 million, net income net loss of $13 million.","evidence_excerpt":"and full year 2025, except where otherwise noted. Total members • 886,000 at year end, up 55% year over year Revenue • $76 million in the fourth quarter, up 58% year over year • $260 million for the full year, up 53% compared with 2024 GLP-1 Leadership • Omada has now supported more than 150,000 members on GLP-1s, compared with more than 50,000 at the end of 2024 •","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001628280-26-015153","anchor_url":"https://secwatch.observer/filing/0001628280-26-015153#claim-c839efe7160af61da869c55b6ea39a5383f149de","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1611115/000162828026015153/0001628280-26-015153-index.htm"},{"fact_type":"earnings_release","fact_key":"c049ccb00f0d6d6db5f256e32ffaecd2d6d168e4","cik":1611115,"ticker":"OMDA","company_name":"Omada Health, Inc.","filed_at":"2026-03-05T23:59:59+00:00","payload":{"eps_text":null,"guidance_signal":"none","item_codes_triggered":["2.02"],"net_income_text":"$5 million","period_text":"the fourth quarter ended December 31, 2025","report_date":"2026-03-05","result_type":"reported_results","revenue_text":"$76 million"},"claim":"Omada Health, Inc. reported the fourth quarter ended December 31, 2025 results: revenue $76 million, net income $5 million.","evidence_excerpt":"Revenue • $76 million in the fourth quarter, up 58% year over year • $260 million for the full year, up 53% compared with 2024","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001628280-26-015153","anchor_url":"https://secwatch.observer/filing/0001628280-26-015153#claim-c049ccb00f0d6d6db5f256e32ffaecd2d6d168e4","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1611115/000162828026015153/0001628280-26-015153-index.htm"},{"fact_type":"governance_change","fact_key":"d7d40a73f4f98f17842c9191dc01de4eb2af5b9a","cik":1611115,"ticker":"OMDA","company_name":"Omada Health, Inc.","filed_at":"2025-06-09T23:59:59+00:00","payload":{"change_type":"bylaw_amendment","effective_date":"2025-06-09","item_codes_triggered":["5.03"],"summary_text":"Amended and restated bylaws became effective in connection with IPO closing"},"claim":"Omada Health, Inc.: Amended and restated bylaws became effective in connection with IPO closing (effective 2025-06-09).","evidence_excerpt":"its amended and restated bylaws (the “Bylaws”) became effective in connection with the closing of the initial public offering of shares of the Company’s common stock","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001193125-25-137809","anchor_url":"https://secwatch.observer/filing/0001193125-25-137809#claim-d7d40a73f4f98f17842c9191dc01de4eb2af5b9a","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1611115/000119312525137809/0001193125-25-137809-index.htm"},{"fact_type":"governance_change","fact_key":"7071d68f7e7fff2f7b297cff6dba28e86b5ea6f7","cik":1611115,"ticker":"OMDA","company_name":"Omada Health, Inc.","filed_at":"2025-06-09T23:59:59+00:00","payload":{"change_type":"charter_amendment","effective_date":"2025-06-09","item_codes_triggered":["5.03"],"summary_text":"Restated certificate of incorporation filed in connection with IPO closing"},"claim":"Omada Health, Inc.: Restated certificate of incorporation filed in connection with IPO closing (effective 2025-06-09).","evidence_excerpt":"On June 9, 2025, Omada Health, Inc. (the “Company”) filed its restated certificate of incorporation (the “Certificate of Incorporation”) with the Secretary of State of the State of Delaware","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001193125-25-137809","anchor_url":"https://secwatch.observer/filing/0001193125-25-137809#claim-7071d68f7e7fff2f7b297cff6dba28e86b5ea6f7","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1611115/000119312525137809/0001193125-25-137809-index.htm"}]}